Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY, 10065, USA.
MAGMA. 2022 Aug;35(4):503-521. doi: 10.1007/s10334-022-01006-6. Epub 2022 Mar 16.
There has been an increasing role of magnetic resonance imaging (MRI) in the management of prostate cancer. MRI already plays an essential role in the detection and staging, with the introduction of functional MRI sequences. Recent advancements in radiomics and artificial intelligence are being tested to potentially improve detection, assessment of aggressiveness, and provide usefulness as a prognostic marker. MRI can improve pretreatment risk stratification and therefore selection of and follow-up of patients for active surveillance. MRI can also assist in guiding targeted biopsy, treatment planning and follow-up after treatment to assess local recurrence. MRI has gained importance in the evaluation of metastatic disease with emerging technology including whole-body MRI and integrated positron emission tomography/MRI, allowing for not only better detection but also quantification. The main goal of this article is to review the most recent advances on MRI in prostate cancer and provide insights into its potential clinical roles from the radiologist's perspective. In each of the sections, specific roles of MRI tailored to each clinical setting are discussed along with its strengths and weakness including already established material related to MRI and the introduction of recent advancements on MRI.
磁共振成像（MRI）在前列腺癌的管理中发挥着越来越重要的作用。随着功能 MRI 序列的引入，MRI 已经在检测和分期中发挥了重要作用。最近在放射组学和人工智能方面的进展正在进行测试，以提高检测、侵袭性评估的能力，并作为预后标志物提供有用信息。MRI 可以改善治疗前的风险分层，从而选择并随访主动监测的患者。MRI 还可以辅助靶向活检、治疗计划以及治疗后随访以评估局部复发。MRI 在评估转移性疾病方面具有重要作用，新兴技术包括全身 MRI 和正电子发射断层扫描/MRI 一体化，不仅可以更好地检测，还可以定量检测。本文的主要目的是回顾 MRI 在前列腺癌中的最新进展，并从放射科医生的角度探讨其潜在的临床作用。在每个章节中，都将讨论 MRI 在特定临床环境下的具体作用及其优缺点，包括与 MRI 相关的已有材料以及 MRI 方面的最新进展。
